DAS
WST icon

Diversify Advisory Services’s West Pharmaceutical WST Stock Holding History

Diversify Advisory Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295K Buy
+891
New +$272K ﹤0.01% 1060
2024
Q2 		– Sell
-686
Closed -$272K – 725
2024
Q1 		$272K Buy
+686
New +$254K 0.02% 550

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Diversify Advisory Services's WST Position: Q2 2026 in Review

Diversify Advisory Services opened a new position in West Pharmaceutical (WST) in Q2 2026: 891 shares worth $295K. The stake represents ﹤0.01% of the portfolio and ranks #1060 among its holdings. This is a return to the name: Diversify Advisory Services previously reported a position in WST as recently as Q1 2024.

Diversify Advisory Services first reported a position in WST in Q1 2024 and has held it in 2 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Diversify Advisory Services held 891 shares of West Pharmaceutical worth $295K as of Q2 2026.
  • West Pharmaceutical was a new Diversify Advisory Services position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Diversify Advisory Services's portfolio in Q2 2026, its #1060 holding.
  • Diversify Advisory Services first reported a position in West Pharmaceutical in Q1 2024 and has held it in 2 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.